The Claim
Elevated high-sensitivity C-reactive protein (hsCRP) levels one month after acute myocardial infarction are associated with worse health status—including symptoms, physical function, and quality of life—at 12 months in young adults, but this association disappears after adjusting for sociodemographic factors, comorbidities, and treatment differences.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Young adults who have higher levels of hsCRP one month after a heart attack tend to report worse symptoms, reduced physical function, and lower quality of life at 12 months, but these differences are no longer observed when accounting for age, income, other health conditions, and medical treatments.
See the scientific wording
Elevated high-sensitivity C-reactive protein (hsCRP) levels one month after acute myocardial infarction are associated with worse health status—including symptoms, physical function, and quality of life—at 12 months in young adults, but this association disappears after adjusting for sociodemographic factors, comorbidities, and treatment differences.
After a heart attack, people with lower income, fewer education, more chronic diseases, or different medications have bodies that sustain higher levels of inflammation and heal less effectively, which leads to worse symptoms and physical function over time.
What the research says
1 studyIn young adults after a heart attack, higher inflammation levels one month later were linked to feeling worse a year later — but once doctors accounted for things like diabetes, income, and medications, that link disappeared.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.